Levemir Novo Nordisk Inc. - Treatment for Diabetes Mellitus (Type 1 and Type 2)Levemir is a novel, long- acting form of insulin that provides up to a 24-hour duration of action for the treatment of diabetes mellitus (type 1 and type 2).
Posted: June 2005
- FDA Approves Levemir for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes - May 22, 2012
- FDA Approves Levemir Pregnancy Category Change for Women with Diabetes - April 2, 2012
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.